← FDA Drug Approvals (Drugs@FDA)

UNLOXCYT

BLA · Biologics License Application · Sponsor: CHECKPOINT THERAPEUTICS INC · Approved 2024-12-13

Drug application

FDA Application #

BLA761297

Application type

Biologics License Application

Brand name

UNLOXCYT

Generic name

COSIBELIMAB

Active ingredients

COSIBELIMAB-IPDL

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

CHECKPOINT THERAPEUTICS INC

Manufacturer

Sun Pharmaceutical Industries, Inc.

First approval

2024-12-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown